Tessera Therapeutics
Devnath Baragada is a Senior Research Associate at Tessera Therapeutics, with previous experience as a Research Associate II at Krystal Biotech, Inc., and as an Assistant/Associate Scientist at Bristol Myers Squibb c/o AllSourcePPS. They have a Master's degree in Chemical Engineering from Purdue University and a Bachelor's degree in Chemical Engineering from the National Institute of Technology Srinagar. Devnath also holds a High School Diploma in Maths, Physics, and Chemistry from Sri Chaitanya Raman Bhavan 1 & 2.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.